CAS: 174302-46-6; 7-Aminoisoquinolin-1(2H)-One

该化合物是化学化合物,其特点是异丙酮结构,具有双环芳香系统,该化合物在异丙酮环的7处放置有氨基组(NH2),有助于其潜在的再活性和生物活动.Isoquinolineones因其不同的药理特性而闻名,包括抗炎,止痛剂和抗微生物效应.氨基氨基化合物的存在可能会增加其在极溶剂中的溶性,影响其与生物目标的相互作用.该化合物通常用于研究环境,特别是医药化学领域,以探索其潜在的治疗应用.其分子结构允许进行各种修改,从而可以导致衍生物的开发,提高效力或选择性.与许多有机化合物一样,由于潜在的毒性或再活性,应当观察到适当的处理和安全措施.

结构式图片

相似化合物

20141-83-7 93117-08-9 1909309-90-5

欧盟法规

C&L通报

上下游产品

7-硝基异喹啉-1(2H)-酮 7-Nitroisoquinolin-1(2H)-One 20141-83-7

合成工艺路线路线简述

  • 491-30-5 = 174302-46-6 + 93117-08-9
    反应条件:1.1 -1.2 Reagents: Potassium Hydride Catalysts: Palladium Solvents: Methanol
    标题:Synergistic Antiviral And Antitumor Compositions Of Poly(Adp Ribose)Transferase (Padprt) Cchc-Oxidizing Ligands And Noncovalent Padprt-Inhibitory Ligands
    参考文献:United States
📜2-甲基-5-硝基苯甲酰氯置于palladium 10% On Activated Carbon,氢气,三氟乙酸体系中,用 四氢呋喃,二氯甲烷,水,甲苯 用作溶剂,化学反应 7.33H,反应生成1(2H)-异喹啉-4,7-氨基(9Ci)
参考文献:Discovery Of Phenylglycine Lactams As Potent Neutral Factor Viia Inhibitors
标题:Discovery Of Phenylglycine Lactams As Potent Neutral Factor Viia Inhibitors
摘要:Inhibitors Of Factor Vila (Fviia),A Serine Protease In The Clotting Cascade,Have Shown Strong Antithrombotic Efficacy In Preclinical Thrombosis Models With Minimal Bleeding Liabilities. Discovery Of Potent,Orally Active Fviia Inhibitors Has Been Largely Unsuccessful Because Known Chemotypes Have Required A Highly Basic Group In The Si Binding Pocket For High Affinity. A Recently Reported Fragment Screening Effort Resulted In The Discovery Of A Neutral Heterocycle,7-Chloro-3,4-Dihydroisoquinolin-1(2H)-One,That Binds In The Si Pocket Of Fviia And Can Be Incorporated Into A Phenylglycine Fviia Inhibitor. Optimization Of This Pi Binding Group Led To The First Series Of Neutral,Permeable Fviia Inhibitors With Low Nanomolar Potency.
Doi:10.1021/acsmedchemlett.6B00282

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1186/s13024-020-00369-5
摘要:Frew J, Baradaran-Heravi A, Balgi AD, Wu X, Yan TD, Arns S, Shidmoossavee FS, Tan J, Jaquith JB, Jansen-West KR, Lynn FC, Gao F, Petrucelli L, Feldman HH, Mackenzie IR, Roberge M, Nygaard HB. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Molecular Neurodegeneration. 2020 Mar 16;15(1):21. doi: 10.1186/s13024-020-00369-5.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知